The mission of the Division of High-Consequence Pathogens and Pathology (DHCPP) is to maximize public health and safety nationally and internationally through the diagnosis, prevention, and control of disease, disability, and death caused by suspected and known viral, bacterial, prion, and related infections.
DHCPP Print Materials
You can order printed copies of some of our publications free of charge. Quantities are limited.
Branches and Offices
Office of the Director
Provides leadership and management for the programs and activities in DHCPP.
One Health Office (OHO)
Works to facilitate, sponsor, and coordinate research and program activities that seek to attain optimal health for people and animals through an integrated approach considering the interrelatedness among humans, animals, and the environment in which they live.
Prion and Public Health Office (PPHO)
Responsible for coordinating various activities and programs related to prion diseases and similar disease outcomes.
Bacterial Special Pathogens Branch (BSPB)
Responsible for the prevention and control of illness and death due to a varied group of zoonotic and environmental bacterial pathogens, and unexplained critical illness and deaths.
Chronic Viral Diseases Branch (CVDB)
Responsible for conducting research on Chronic Fatigue Syndrome (CFS) and factors that relate to this illness and for laboratory-based studies of human papilloma virus (HPV).
Infectious Diseases Pathology Branch (IDPB)
Responsible for conducting laboratory studies and investigations of severe infectious disease of unknown etiologies. Additionally, IDPB works to identify new or previously unrecognized pathogens.
Poxvirus and Rabies Branch
Responsible for surveillance, control, and prevention of illness and death due to poxviruses and rabies.
Viral Special Pathogens Branch (VSPB)
Responsible for the investigation of Ebolavirus, Marburgvirus, Lassa fever virus, Rift Valley fever virus, Crimean-Congo hemorrhagic fever virus, other Arenavirus and Hantavirus species, and additional recently identified and emerging viral species.